CVRx commences enrollment in study evaluating the Rheos System to take care of heart failure CVRx.

Fred Weaver at The University of Southern California.. CVRx commences enrollment in study evaluating the Rheos System to take care of heart failure CVRx, Inc. Reported the first enrollment of a patient in the HOPE4HF Trial, a study that is evaluating the Rheos Program to treat heart failure. The HOPE4HF Trial is being conducted under an approved investigational gadget exemption from the U.S. Food and Drug Administration . Data from this pivotal trial are intended to support a Pre-Market Approval application to the FDA for use of the Rheos System in heart failure.S. We are hopeful the Rheos System will improve their quality of life, and reduce hospitalizations, along with the risk of death.Regarding to Marillier-Malotana, it could be more effective for local HIV/Helps programs if local rather than international celebrities were involved. Marillier-Malotana provides initiated an artists’ forum that includes Zimbabwean poets, musicians and actors to discuss HIV/AIDS issues. The forum allows performers to become ‘candid’ about HIV/Helps, Marillier-Malotana said, adding that the mixed group hopes to open up an HIV/AIDS testing and guidance center for artists. Related StoriesStudy: Safe spaces may play critical part in community-based HIV avoidance effortsBrown University experts describe new solution to test HIV mutationsNew study finds high prevalence of HIV among pregnant refugee ladies in OntarioAccording to the Gazette/AllAfrica.com, the centers shall be promoted through the SADC area, and they will help people living with and affected by HIV/AIDS.